Skip to main content
. 2008 Jun 6;466(9):2099–2106. doi: 10.1007/s11999-008-0330-4

Fig. 4.

Fig. 4

Tumor-specific survival of 210 patients with M0 gastrointestinal stromal tumors according to the expression of pfetin protein in the primary tumor samples examined by immunohistochemistry. Patients with tumors expressing pfetin (n = 171) had better (p < 0.0001) survival (5-year survival, 97.2%) than those with tumors lacking pfetin expression (n = 39) (5-year survival, 76.5%).